LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,187
تعداد مقالات10,824
تعداد مشاهده مقاله72,829,262
تعداد دریافت فایل اصل مقاله12,909,487
Wu, Hong, Fu, Yanqi, Jiang, Yuhuan, Liu, Yali, Cheng, Zhibin, Shao, Yanting, Nie, Yijun. (1402). High-free Fatty Acid Treatment Induced Anti-inflammatory Changes in a Natural Killer (NK) Cell Line. سامانه مدیریت نشریات علمی, 20(4), 456-465. doi: 10.22034/iji.2023.99972.2670
Hong Wu; Yanqi Fu; Yuhuan Jiang; Yali Liu; Zhibin Cheng; Yanting Shao; Yijun Nie. "High-free Fatty Acid Treatment Induced Anti-inflammatory Changes in a Natural Killer (NK) Cell Line". سامانه مدیریت نشریات علمی, 20, 4, 1402, 456-465. doi: 10.22034/iji.2023.99972.2670
Wu, Hong, Fu, Yanqi, Jiang, Yuhuan, Liu, Yali, Cheng, Zhibin, Shao, Yanting, Nie, Yijun. (1402). 'High-free Fatty Acid Treatment Induced Anti-inflammatory Changes in a Natural Killer (NK) Cell Line', سامانه مدیریت نشریات علمی, 20(4), pp. 456-465. doi: 10.22034/iji.2023.99972.2670
Wu, Hong, Fu, Yanqi, Jiang, Yuhuan, Liu, Yali, Cheng, Zhibin, Shao, Yanting, Nie, Yijun. High-free Fatty Acid Treatment Induced Anti-inflammatory Changes in a Natural Killer (NK) Cell Line. سامانه مدیریت نشریات علمی, 1402; 20(4): 456-465. doi: 10.22034/iji.2023.99972.2670

High-free Fatty Acid Treatment Induced Anti-inflammatory Changes in a Natural Killer (NK) Cell Line

Iranian Journal of Immunology
مقاله 7، دوره 20، شماره 4، اسفند 2023، صفحه 456-465    اصل مقاله (2.33 M)
نوع مقاله: Original Article
شناسه دیجیتال (DOI): 10.22034/iji.2023.99972.2670
نویسندگان
Hong Wu1، 2، 3؛ Yanqi Fu1، 2؛ Yuhuan Jiang4؛ Yali Liu3، 5؛ Zhibin Cheng2؛ Yanting Shao2؛ Yijun Nie* 4
1Department of Laboratory Medicine, Jiangxi Health Vocational College, Nanchang, Jiangxi 330052, China.
2School of Laboratory Medicine, Nanchang Medical College, Nanchang, Jiangxi 330052, China.
3Key Laboratory of Pharmacodynamics and Safety Evaluation, Health Commission of Jiangxi Province, Nanchang, Jiangxi 330052, China.
4Department of Clinical Laboratory, First Affiliated Hospital, Medical College of Nanchang University, Nanchang, Jiangxi 330006, China.
5Key Laboratory of Pharmacodynamics and Quality Evaluation on Anti-Inflammatory Chinese Herbs, Jiangxi Administration of Traditional Chinese Medicine, Nanchang, Jiangxi 330052, China.
چکیده
Background: Natural killer (NK) cells play a role in the pathogenesis of various metabolic diseases related to obesity. While our initial findings have indicated a potential involvement of NK cells in the pathogenesis of type 2 diabetes mellitus, the precise mechanism underlying NK cell-mediated development of this form of diabetes remains inadequately comprehended.
Objective: To investigate the impact and the underlying mechanism of high glucose and elevated levels of free fatty acids (FFAs) on immune and inflammatory responses and oxidative stress in NK92 cells.
Methods: In this experiment, the CCK8 cytotoxicity assay was used to select the 44.4 mM and 1.5 mM concentrations of high glucose and high FFAs, respectively, to treat NK92 cells for 4 days. The concentrations of superoxide dismutase (SOD) and glutathione (GSH) were determined using a biochemical analyzer. Intracellular reactive oxygen species (ROS) levels, cytokines concentrations (TNF-α, IFN-γ, IL-6, and IL-10), and the expression levels of intracellular molecules (perforin and granzyme B) were assessed by flow cytometry.
Results: The number of NK92 cell clumps was significantly reduced in the high-FFA (HF) group. In addition, the production of ROS and levels of cytokines (TNF-α, IFN-γ, IL-6, and IL-10) significantly decreased in the HF group but showed no significant change in the high-glucose (HG) group. This observation was consistent with the expression levels of perforin and granzyme B that decreased in the HF group.
Conclusion: High FFAs induced morphological changes and serious damage to oxidative stress and inflammatory response in NK92 cells.
کلیدواژه‌ها
Cytokines؛ High FFA؛ Intracellular Molecules؛ NK92 Cells؛ Oxidative Stress
مراجع
  1. Glovaci D, Fan W, Wong ND. Epidemiology of Diabetes Mellitus and Cardiovascular Disease. Curr Cardiol Rep. 2019,21(4):21.
  2. Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of Type 2 Diabetes Mellitus. Int J Mol Sci. 2020,21(17):6275.
  3. Hirano T. Pathophysiology of Diabetic Dyslipidemia. J Atheroscler Thromb. 2018,25(9):771-782.
  4. Mitri J, Tomah S, Furtado J, Tasabehji MW, Hamdy O. Plasma Free Fatty Acids and Metabolic Effect in Type 2 Diabetes, an Ancillary Study from a Randomized Clinical Trial. Nutrients. 2021,13(4):1145.
  5. Yilmaz A, Cui H, Caligiuri MA, Yu J. Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy. J Hematol Oncol. 2020,13(1):168.
  6. Kundu S, Gurney M, O'Dwyer M. Generating natural killer cells for adoptive transfer: expanding horizons. Cytotherapy. 2021,23(7):559-66.
  7. Sivori S, Pende D, Quatrini L, Pietra G, Della Chiesa M, Vacca P, et al. NK cells and ILCs in tumor immunotherapy. Mol Aspects Med. 2021,80(8):100870.
  8. Kucuksezer UC, Aktas Cetin E, Esen F, Tahrali I, Akdeniz N, Gelmez MY, et al. The Role of Natural Killer Cells in Autoimmune Diseases. Front Immunol. 2021,25(2):622306.
  9. Li Y, Wang F, Imani S, Tao L, Deng Y, Cai Y. Natural Killer Cells: Friend or Foe in Metabolic Diseases? Front Immunol. 2021,24(2):614429.
  10. Bonamichi BDSF, Lee J. Unusual Suspects in the Development of Obesity-Induced Inflammation and Insulin Resistance: NK cells, iNKT cells, and ILCs. Diabetes Metab J. 2017,41(4):229-50.
  11. Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017,127(1):1-4.
  12. Patsouris D, Li PP, Thapar D, Chapman J, Olefsky JM, Neels JG. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab. 2008,8(4):301-9.
  13. Wang H, Cao K, Liu S, Xu Y, Tang L. Tim-3 Expression Causes NK Cell Dysfunction in Type 2 Diabetes Patients. Front Immunol. 2022,13(4):852436.
  14. Fernø J, Strand K, Mellgren G, Stiglund N, Björkström NK. Natural Killer Cells as Sensors of Adipose Tissue Stress. Trends Endocrinol Metab. 2020,31(1):3-12.
  15. Wu H, Nie Y. Proportion of natural killer cells in peripheral blood lymphocytes is correlated with cytokine levels in patients with type 2 diabetes mellitus and prediabetes: a preliminary report.Int J Diabetes Dev Ctries.2022, 42(4):781–786.
  16. Peng H, Xiang T, Xu F, Jiang Y, Zhong L, Peng Y, et al. Redistribution and Activation of CD16 brightCD56dim NK Cell Subset to Fight against Omicron Subvariant BA.2 after COVID-19 Vaccination. Microorganisms. 2023,11(4):940.
  17. Donath MY, Dinarello CA, Mandrup-Poulsen T. Targeting innate immune mediators in type 1 and type 2 diabetes. Nat Rev Immunol. 2019,19(12):734-746.
  18. Abel AM, Yang C, Thakar MS, Malarkannan S. Natural Killer Cells: Development, Maturation, and Clinical Utilization. Front Immunol. 2018,13(8):1869.
  19. Wu H, Nie Y, Xiong H, Liu S, Li G, Huang A, et al. P2X7 Receptor Expression in Peripheral Blood Monocytes Is Correlated With Plasma C-Reactive Protein and Cytokine Levels in Patients With Type 2 Diabetes Mellitus: a Preliminary Report. Inflammation. 2015, 38(6):2076-81.
  20. Gong JH, Maki G, Klingemann HG. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia. 1994,8(4):652-8.
  21. Fabian KP, Hodge JW. The emerging role of off-the-shelf engineered natural killer cells in targeted cancer immunotherapy. Mol Ther Oncolytics. 2021,23(10):266-76.
  22. Kim JH, Park K, Lee SB, Kang S, Park JS, Ahn CW, et al. Relationship between natural killer cell activity and glucose control in patients with type 2 diabetes and prediabetes. J Diabetes Investig. 2019,10(5):1223-228.
  23. Lv X, Gao Y, Dong T, Yang L. Role of Natural Killer T (NKT) Cells in Type II Diabetes-Induced Vascular Injuries. Med Sci Monit. 2018, 24(11):8322-332.
  24. Bergman H, Lindqvist C. Human IL-15 Inhibits NK Cells Specific for Human NK-92 Cells. Anticancer Res. 2021,41(7):3281-285.
  25. Wang X, Liang C, Xia W, Guo C, Niu Z, Zhu W, et al. VEGF165b augments NK92 cytolytic activity against human K562 leukemia cells by upregulating the levels of perforin and granzyme B via the VEGR1-PLC pathway. Mol Immunol. 2020,128(12):41-6.
  26. Liguori I, Russo G, Curcio F, Bulli G, Aran L, Della-Morte D, et al. Oxidative stress, aging, and diseases. Clin Interv Aging. 2018, 13(4):757-72.
  27. Laforge M, Elbim C, Frère C, Hémadi M, Massaad C, Nuss P, et al. Tissue damage from neutrophil-induced oxidative stress in COVID-19. Nat Rev Immunol. 2020,20(9):515-16.
  28. Morris G, Gevezova M, Sarafian V, Maes M. Redox regulation of the immune response. Cell Mol Immunol. 2022,19(10):1079-101.
  29. Assmann N, O'Brien KL, Donnelly RP, Dyck L, Zaiatz-Bittencourt V, Loftus RM, et al. Srebp-controlled glucose metabolism is essential for NK cell functional responses. Nat Immunol. 2017,18(11):1197-206.
  30. Millman AC, Salman M, Dayaram YK, Connell ND, Venketaraman V. Natural killer cells, glutathione, cytokines, and innate immunity against Mycobacterium tuberculosis. J Interferon Cytokine Res. 2008,28(3):153-65.
  31. Gajovic N, Jurisevic M, Pantic J, Radosavljevic G, Arsenijevic N, Lukic ML, et al. Attenuation of NK cells facilitates mammary tumor growth in streptozotocin-induced diabetes in mice. Endocr Relat Cancer. 2018,25(4):493-507.
  32. Tuomela K, Ambrose AR, Davis DM. Escaping Death: How Cancer Cells and Infected Cells Resist Cell-Mediated Cytotoxicity. Front Immunol. 2022,13(3):867098.
  33. Prager I, Liesche C, van Ooijen H, Urlaub D, Verron Q, Sandström N, et al. NK cells switch from granzyme B to death receptor-mediated cytotoxicity during serial killing. J Exp Med. 2019,216(9):2113-127.
  34. Sordo-Bahamonde C, Lorenzo-Herrero S, Payer ÁR, Gonzalez S, López-Soto A. Mechanisms of Apoptosis Resistance to NK Cell-Mediated Cytotoxicity in Cancer. Int J Mol Sci. 2020,21(10):3726.
آمار
تعداد مشاهده مقاله: 790
تعداد دریافت فایل اصل مقاله: 622


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب